Cargando…
Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases
As the population ages, neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) impose a heavy burden on society and families. The pathogeneses of PD and AD are complex. There are no radical cures for the diseases, and existing therapeutic agents for PD and AD have d...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017384/ https://www.ncbi.nlm.nih.gov/pubmed/29495349 http://dx.doi.org/10.3390/molecules23030512 |
_version_ | 1783334737236983808 |
---|---|
author | Chen, Shu-Qing Wang, Ze-Shi Ma, Yi-Xiao Zhang, Wei Lu, Jian-Liang Liang, Yue-Rong Zheng, Xin-Qiang |
author_facet | Chen, Shu-Qing Wang, Ze-Shi Ma, Yi-Xiao Zhang, Wei Lu, Jian-Liang Liang, Yue-Rong Zheng, Xin-Qiang |
author_sort | Chen, Shu-Qing |
collection | PubMed |
description | As the population ages, neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) impose a heavy burden on society and families. The pathogeneses of PD and AD are complex. There are no radical cures for the diseases, and existing therapeutic agents for PD and AD have diverse side effects. Tea contains many bioactive components such as polyphenols, theanine, caffeine, and theaflavins. Some investigations of epidemiology have demonstrated that drinking tea can decrease the risk of PD and AD. Tea polyphenols can lower the morbidity of PD and AD by reducing oxidative stress and regulating signaling pathways and metal chelation. Theanine can inhibit the glutamate receptors and regulate the extracellular concentration of glutamine, presenting neuroprotective effects. Additionally, the neuroprotective mechanisms of caffeine and theaflavins may contribute to the ability to antagonize the adenosine receptor A(2A)R and the antioxidant properties, respectively. Thus, tea bioactive components might be useful for neuronal degeneration treatment in the future. In the present paper, the neuro protection and the mechanisms of tea and its bioactive components are reviewed. Moreover, the potential challenges and future work are also discussed. |
format | Online Article Text |
id | pubmed-6017384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60173842018-11-13 Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases Chen, Shu-Qing Wang, Ze-Shi Ma, Yi-Xiao Zhang, Wei Lu, Jian-Liang Liang, Yue-Rong Zheng, Xin-Qiang Molecules Review As the population ages, neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) impose a heavy burden on society and families. The pathogeneses of PD and AD are complex. There are no radical cures for the diseases, and existing therapeutic agents for PD and AD have diverse side effects. Tea contains many bioactive components such as polyphenols, theanine, caffeine, and theaflavins. Some investigations of epidemiology have demonstrated that drinking tea can decrease the risk of PD and AD. Tea polyphenols can lower the morbidity of PD and AD by reducing oxidative stress and regulating signaling pathways and metal chelation. Theanine can inhibit the glutamate receptors and regulate the extracellular concentration of glutamine, presenting neuroprotective effects. Additionally, the neuroprotective mechanisms of caffeine and theaflavins may contribute to the ability to antagonize the adenosine receptor A(2A)R and the antioxidant properties, respectively. Thus, tea bioactive components might be useful for neuronal degeneration treatment in the future. In the present paper, the neuro protection and the mechanisms of tea and its bioactive components are reviewed. Moreover, the potential challenges and future work are also discussed. MDPI 2018-02-25 /pmc/articles/PMC6017384/ /pubmed/29495349 http://dx.doi.org/10.3390/molecules23030512 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Chen, Shu-Qing Wang, Ze-Shi Ma, Yi-Xiao Zhang, Wei Lu, Jian-Liang Liang, Yue-Rong Zheng, Xin-Qiang Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases |
title | Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases |
title_full | Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases |
title_fullStr | Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases |
title_full_unstemmed | Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases |
title_short | Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases |
title_sort | neuroprotective effects and mechanisms of tea bioactive components in neurodegenerative diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017384/ https://www.ncbi.nlm.nih.gov/pubmed/29495349 http://dx.doi.org/10.3390/molecules23030512 |
work_keys_str_mv | AT chenshuqing neuroprotectiveeffectsandmechanismsofteabioactivecomponentsinneurodegenerativediseases AT wangzeshi neuroprotectiveeffectsandmechanismsofteabioactivecomponentsinneurodegenerativediseases AT mayixiao neuroprotectiveeffectsandmechanismsofteabioactivecomponentsinneurodegenerativediseases AT zhangwei neuroprotectiveeffectsandmechanismsofteabioactivecomponentsinneurodegenerativediseases AT lujianliang neuroprotectiveeffectsandmechanismsofteabioactivecomponentsinneurodegenerativediseases AT liangyuerong neuroprotectiveeffectsandmechanismsofteabioactivecomponentsinneurodegenerativediseases AT zhengxinqiang neuroprotectiveeffectsandmechanismsofteabioactivecomponentsinneurodegenerativediseases |